CN115246873A - Syngnathus characteristic polypeptide, application thereof and method for identifying Syngnathus - Google Patents
Syngnathus characteristic polypeptide, application thereof and method for identifying Syngnathus Download PDFInfo
- Publication number
- CN115246873A CN115246873A CN202210653950.9A CN202210653950A CN115246873A CN 115246873 A CN115246873 A CN 115246873A CN 202210653950 A CN202210653950 A CN 202210653950A CN 115246873 A CN115246873 A CN 115246873A
- Authority
- CN
- China
- Prior art keywords
- syngnathus
- mass
- solution
- seq
- charge ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001478428 Syngnathus Species 0.000 title claims abstract description 114
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 36
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 35
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 33
- 238000001514 detection method Methods 0.000 claims abstract description 13
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 6
- 150000002500 ions Chemical class 0.000 claims description 52
- 239000000284 extract Substances 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 26
- 102000004142 Trypsin Human genes 0.000 claims description 21
- 108090000631 Trypsin Proteins 0.000 claims description 21
- 239000012588 trypsin Substances 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 241001540526 Leptonotus elevatus Species 0.000 claims description 16
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 15
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 15
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 15
- 239000001099 ammonium carbonate Substances 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 238000005173 quadrupole mass spectroscopy Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000012085 test solution Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 238000004949 mass spectrometry Methods 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- KKTCWAXMXADOBB-UHFFFAOYSA-N azanium;hydrogen carbonate;hydrate Chemical compound [NH4+].O.OC([O-])=O KKTCWAXMXADOBB-UHFFFAOYSA-N 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 239000012088 reference solution Substances 0.000 claims 1
- 239000013558 reference substance Substances 0.000 description 14
- 241000894007 species Species 0.000 description 13
- 102000007079 Peptide Fragments Human genes 0.000 description 9
- 108010033276 Peptide Fragments Proteins 0.000 description 9
- 238000001819 mass spectrum Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241001478511 Syngnathus schlegeli Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 241000587240 Cynanchum Species 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- 241000331449 Vincetoxicum pycnostelma Species 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002552 multiple reaction monitoring Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- HZPSDHRYYIORKR-WHFBIAKZSA-N Asn-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O HZPSDHRYYIORKR-WHFBIAKZSA-N 0.000 description 1
- 241000862992 Chondromyces Species 0.000 description 1
- 241000270293 Elaphe Species 0.000 description 1
- 241001113926 Gelsemium Species 0.000 description 1
- ININBLZFFVOQIO-JHEQGTHGSA-N Gln-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O ININBLZFFVOQIO-JHEQGTHGSA-N 0.000 description 1
- 238000013051 Liquid chromatography–high-resolution mass spectrometry Methods 0.000 description 1
- 241000408521 Lucida Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241001303775 Phlomis Species 0.000 description 1
- 241001257016 Platyphylla Species 0.000 description 1
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 1
- ZPPVJIJMIKTERM-YUMQZZPRSA-N Pro-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1 ZPPVJIJMIKTERM-YUMQZZPRSA-N 0.000 description 1
- DMKWYMWNEKIPFC-IUCAKERBSA-N Pro-Gly-Arg Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O DMKWYMWNEKIPFC-IUCAKERBSA-N 0.000 description 1
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000344244 Rhynchophorus Species 0.000 description 1
- 240000008301 Rhynchosia minima Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000337587 Syngnathus acus Species 0.000 description 1
- ZTPXSEUVYNNZRB-CDMKHQONSA-N Thr-Gly-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZTPXSEUVYNNZRB-CDMKHQONSA-N 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention relates to a syngnathus pseudopterus characteristic polypeptide, application thereof and a method for identifying the syngnathus pseudopterus, belonging to the technical field of biotechnology detection. The invention provides two unique characteristic polypeptides of syngnathus, and the amino acid sequences of the characteristic polypeptides are shown in SEQ ID NO.1 and SEQ ID NO. 2. The characteristic polypeptide provided by the invention has excellent specificity and stability for the syngnathus mimicus, has strong specificity, can be used for identifying the syngnathus mimicus, and has good application prospect.
Description
Technical Field
The invention relates to the technical field of biotechnology detection, in particular to two Syngnathus characteristic polypeptides, application thereof and a method for identifying Syngnathus.
Background
The Syngnathus is an important animal medicinal material in China, has the effects of warming kidney, tonifying yang, resolving masses and relieving swelling, and has long administration history and numerous primordial sources. The pharmaceutical base source of Syngnathus is defined in the Chinese pharmacopoeia as dried bodies of Syngnathus caudatum hardwickii (Gray), syngnathus biaceutus (Bloch) or Syngnathus acus cusa cusLinnaeus, which are Syngnathus animals of the Syngnaceae family.
The sea dragon as a tonifying medicinal material has an increasing market demand year by year, and the price of the sea dragon in the market is gradually increased because the sea dragon cannot effectively realize artificial breeding and the wild resource of the sea dragon is gradually reduced at present. The sea dragon is not only used as a raw material and directly crushed or extracted to prepare a Chinese patent medicine, but also is often prepared into sea dragon tonic wine to be used as a health-care tonic product.
The species identification and quality control methods of the current Syngnathus mainly comprise a sex identification method, an HPLC fingerprint spectrum method and a molecular biology method. The character identification method generally requires that the sea dragon individual is complete, and the person needing to be identified has rich experience, and the method has certain subjectivity; the specificity of an HPLC fingerprint spectrum method is low; the molecular biology method has high specificity, but is limited by the intact preservation degree of genetic materials in samples, and for the samples of the Syngnathus medicated liquor, the processed products, the extracts, the worm-eaten mildew and a plurality of individual mixed samples, the successful experiment can not be carried out due to the difficulty in extracting DNA. In recent years, more and more methods and standards have been used to identify or quantify natural drugs using characteristic peptide fragments. The protein contained in each species has difference of amino acid at individual site, and the difference site can be intercepted by using proper protease to be used as polypeptide segment with identification meaning, i.e. characteristic peptide segment. The detection of the characteristic peptide fragment generally uses a mass spectrum means, protein activity does not need to be considered, the preparation method is simple, and the property of the peptide fragment is relatively stable. The existing method for identifying the Syngnathus has more limiting factors, can not be applied to derivative products such as Syngnathus powder, syngnathus medicated liquor, processed products, extracts and the like, and the characteristic peptide segment in the Syngnathus protein has potential to be used as an index component for identifying the species of the Syngnathus. At present, no Syngnathus-related protein sequence information is collected in each database, and a differential peptide segment cannot be obtained through protein sequence comparison, so that no related records of Syngnathus-characteristic polypeptides exist.
Disclosure of Invention
The invention aims to provide two quasi-sea dragon characteristic polypeptides, application thereof and a method for identifying the quasi-sea dragon. The characteristic polypeptide provided by the invention has excellent specificity and stability for the syngnathus, has strong specificity, can be used for identifying the species of the medicinal material of the syngnathus, particularly the species of the syngnathus, and has good application prospect.
The invention provides two quasi-sea dragon characteristic polypeptides, wherein the amino acid sequences of the characteristic polypeptides are shown as SEQ ID NO.1 and SEQ ID NO. 2.
The invention also provides application of the characteristic polypeptide in the technical scheme in identifying the Syngnathus.
Further, the application of SEQ ID NO.1 and SEQ ID NO.2 in identifying the Syngnathus independently or together.
Preferably, the identifying is performed using mass spectrometry, and detecting the ion pair comprises: SEQ ID No.1 is a quantitative ion with mass-to-charge ratio of m/z 639.6 → 810.2 and a qualitative ion with mass-to-charge ratio of m/z 639.6 → 753.1; the mass-to-charge ratio of the quantitative ion of SEQ ID NO.2 is m/z852.1 → 1144.6, and the mass-to-charge ratio of the qualitative ion of m/z852.1 → 875.4.
The invention also provides an identification method of the Syngnathus pseudopterus, which adopts the characteristic polypeptide shown in SEQ ID NO.1 and/or SEQ ID NO.2 as a reference substance.
The invention also provides a method for identifying the Syngnathus based on the characteristic polypeptide, which comprises the following steps:
(1) Preparation of a test solution: mixing the pretreated pipefish powder extract or the pretreated pipefish medicinal liquor extract with trypsin respectively to obtain a mixed solution, mixing the mixed solution with an ammonium bicarbonate aqueous solution, carrying out enzymolysis and filtering, and taking a filtrate to obtain a test solution;
(2) Preparation of control solutions: the sea-like dragon characteristic peptide is used as a reference substance, and water is added for dissolving to obtain a reference substance solution;
(3) Detection and analysis: detecting and analyzing by using a triple quadrupole mass spectrometry;
the step (1) or the step (2) is not limited in chronological order.
Preferably, in the step (1), the preparation method of the pretreated pipefish powder extract comprises the following steps: mixing Syngnathus powder with water, decocting for three times (4 h,3h and 2 h), mixing decoctions, and diluting with ammonium bicarbonate water solution to obtain pretreated Syngnathus powder extractive solution;
the preparation process of the pretreated Syngnathus medicinal liquor extract comprises the following steps: taking out Syngnathus in Syngnathus medicated liquor, drying at low temperature, decocting with water for three times (4 hr, 3 hr and 2 hr respectively), mixing decoctions, filtering, and collecting filtrate to obtain pretreated Syngnathus medicated liquor extract;
preferably, the trypsin is added in the form of an aqueous trypsin solution, and the mass concentration of the trypsin in the aqueous trypsin solution is 1mg/ml.
Preferably, the mass percentage content of ammonium bicarbonate in the ammonium bicarbonate aqueous solution is 1%.
Preferably, the enzymolysis condition is enzymolysis at 37 ℃ for 2h.
Preferably, the triple quadrupole mass spectrometry is performed by taking 0.1% formic acid acetonitrile as a mobile phase A and 0.1% formic acid solution as a mobile phase B, and performing gradient elution: 0-3min, 5%; the flow rate was 0.5ml per minute.
Preferably, the triple quadrupole mass spectrometry adopts a mass spectrometry detector and an electrospray positive ion mode to carry out multi-reaction monitoring, wherein the SEQ ID NO.1 selects a quantitative ion with a mass-to-charge ratio of m/z 639.6 → 810.2, the qualitative ion with a mass-to-charge ratio of m/z 639.6 → 753.1 is taken as a detection ion pair, the SEQ ID NO.2 selects a quantitative ion with a mass-to-charge ratio of m/z852.1 → 1144.6, and the qualitative ion with a mass-to-charge ratio of m/z852.1 → 875.4 is taken as a detection ion pair.
The invention provides two polypeptides with characteristics of syngnathus. The characteristic polypeptide provided by the invention is used as an index component for identifying the Syngnathus, can be distinguished from the Syngnathus of other species, and lays a foundation for developing methods for identifying the Syngnathus and related products. Specifically, the characteristic polypeptide of the invention has the following beneficial effects:
(1) The method intercepts the difference polypeptide segments in the protein sequence, adopts mass spectrum for detection, has simple and rapid operation and stable determination result, is not interfered by the shape and the processing process of a Syngnathus sample, and fills the blank of the method for identifying the species of the Syngnathus pseudosea and detecting the Syngnathus in the Syngnathus product;
(2) The characteristic polypeptide and the detection method provided by the invention provide reference for searching characteristic peptide segments in related species lacking in a database;
(3) The characteristic polypeptide provided by the invention has excellent specificity and stability for the syngnathus, has strong specificity, can be used for identifying the medicinal material of the syngnathus, and has good application prospect.
Drawings
FIGS. 1-9 are the specificity maps of the Syngnathus pseudopeptide SEQ ID NO.1 provided by the present invention; wherein FIG. 1 is the M/z 639.6 → 810.2, 753.1 map of SEQ ID NO.1 reference substance, and FIGS. 2-9 are the m/z 639.6 → 810.2, 753.1 maps extracted from Syngnathus pseudosea, cynanchum paniculatum, syngnathus schlegeli, dowanese Syngnathus polycephalus, baojia Syngnathus, elaphe robusta, rhynchosia lucida, phlomis gesii, and Rhynchophorus glehnsonii in sequence.
FIGS. 10-18 are the Syngnathus pseudopeptides SEQ ID NO.2 specificity profiles provided by the present invention; wherein FIG. 10 is the M/z852.1 → 1144.6 and 875.4 maps of SEQ ID NO.2 reference substance, and FIGS. 11-18 are the m/z852.1 → 1144.6 and 875.4 maps of Syngnathus niponicas, cynanchum paniculatum, syngnathus schlegeli, syngnathus polygama, syngnathus galaxacum, syngnathus alurus, syngnathus crassimus, syngnathus platyphylla, and Syngnathus gelloides.
Detailed Description
The invention provides two sea dragon simulating characteristic polypeptides, wherein the amino acid sequence of the characteristic polypeptides is shown as SEQ ID NO.1: NAGPQGPQGAAGPR, SEQ ID NO.2: QTGGAGSPATTGFPSGPGR. The invention provides a peptide fragment with characteristic recognition significance for syngnathus. The method comprises the steps of carrying out trypsin enzymolysis on water extracts of different kinds of Syngnathus such as Syngnathus pseudognathus, cynanchum brachypomum, cynanchum polycephalum, syngnathus schlegeli, etc., and analyzing by using a nanoliter liquid chromatography-high resolution mass spectrometer to obtain a Syngnathus protein complete peptide fragment mass spectrogram; carrying out chemometric analysis on the mass spectrum data, and then carrying out specificity verification on the experimental result by using a triple quadrupole mass spectrum; finally, 2 characteristic ion pairs are provided, corresponding to 2 characteristic peptide fragments, and the specificity verification result is good.
The invention also provides application of the characteristic polypeptide in the technical scheme in identifying the Syngnathus.
In the present invention, the identifying is performed using mass spectrometry, and detecting the ion pair comprises: SEQ ID No.1 is a quantitative ion with mass-to-charge ratio of m/z 639.6 → 810.2 and a qualitative ion with mass-to-charge ratio of m/z 639.6 → 753.1; the mass-to-charge ratio of the quantitative ion with the SEQ ID NO.2 is m/z852.1 → 1144.6, and the mass-to-charge ratio of the qualitative ion with the m/z852.1 → 875.4.
The invention also provides a method for identifying the Syngnathus based on the characteristic polypeptide, which comprises the following steps:
(1) Mixing the pretreated pipefish powder extract or the pretreated pipefish medicinal liquor extract with trypsin respectively to obtain a mixed solution, mixing the mixed solution with an ammonium bicarbonate aqueous solution, carrying out enzymolysis and filtering, and taking a filtrate to obtain a test solution;
(2) Adding an ammonium bicarbonate aqueous solution to dissolve the syngnathus pseudopterus characteristic peptide serving as a reference substance in the technical scheme to obtain a reference substance solution;
(3) Detecting and analyzing by using a triple quadrupole mass spectrometry;
the steps (1) or (2) are not limited in chronological order.
The method provided by the invention intercepts the differential polypeptide segments in the protein sequence, adopts mass spectrum for detection, is simple and rapid to operate, has stable determination result, is not interfered by the form and the processing process of a Syngnathus sample, fills the blank of the method for identifying the Syngnathus pseudopterus species and detecting the Syngnathus in the Syngnathus product, and provides reference for searching the characteristic peptide segments in the kindred species lacking in the database.
Mixing the pretreated pipefish powder extract or the pretreated pipefish medicinal liquor extract with trypsin to obtain a mixed solution, mixing the mixed solution with an ammonium bicarbonate aqueous solution, carrying out enzymolysis and filtering, and taking a filtrate to obtain a test solution. In the present invention, the preparation method of the pretreated pipefish powder extract preferably comprises the following steps: mixing Syngnathus powder with water, decocting for three times (4 h,3h and 2h respectively), and mixing decoctions to obtain pretreated Syngnathus powder extract. The invention preferably selects 1g of Syngnathus powder, and the total amount of the decoction is preferably 50mL. Specifically, the method preferably takes 5mL of the decoction, places the decoction in a 50mL measuring flask, uses an ammonium bicarbonate aqueous solution to dilute the decoction to a scale, and shakes the solution uniformly to obtain the pretreated pipefish powder extracting solution. In the present invention, the preparation process of the pretreated Syngnathus medicated liquor extract preferably comprises the following steps: taking out Syngnathus in Syngnathus medicated liquor, drying at low temperature, decocting with water for three times (4 hr, 3 hr and 2 hr respectively), mixing decoctions, filtering, and collecting filtrate to obtain pretreated Syngnathus medicated liquor extract. After obtaining the pretreated pipefish extract and the pretreated pipefish medicinal liquor extract, the invention preferably measures 1-5 mL pipefish powder extract or pipefish medicinal liquor extract, preferably adds 100 μ L trypsin solution, shakes evenly, adds ammonium bicarbonate aqueous solution to 50mL, shakes evenly, carries out enzymolysis after sealing. In the present invention, the enzymolysis condition is preferably enzymolysis at 37 ℃ for 2h. After enzymolysis, the method is preferably cooled, more preferably to normal temperature, and the temperature range of the normal temperature is preferably 10-30 ℃. After cooling, the invention filters and takes the filtrate as the test solution.
In the invention, the trypsin is added in the form of an aqueous trypsin solution, and the mass concentration of the trypsin in the aqueous trypsin solution is 1mg/ml. In the invention, the mass percentage of ammonium bicarbonate in the ammonium bicarbonate aqueous solution is 1%.
The invention takes the pseudo-sea dragon characteristic peptide as a reference substance, and water is added for dissolution to obtain a reference substance solution. The source of the Syngnathus pseudopeptides is not particularly limited, and the Syngnathus pseudopeptides can be obtained by artificial synthesis, for example, 2 Syngnathus pseudopeptides of the invention are obtained by entrusted Nanjing peptide Biotech limited according to the specified amino acid sequence.
The invention utilizes triple quadrupole mass spectrometry to carry out detection and analysis. In the present invention, the triple quadrupole mass spectrometry is preferably performed by gradient elution with 0.1% formic acid acetonitrile as mobile phase a and 0.1% formic acid solution as mobile phase B: 0 to 3min,5% by weight A → 8% by weight A; the flow rate was 0.5ml per minute. In the invention, the triple quadrupole mass spectrometry is preferably carried out by adopting a mass spectrometry detector in an electrospray positive ion mode, and multiple reactions are monitored, wherein the SEQ ID NO.1 selects a quantitative ion with a mass-to-charge ratio of m/z 639.6 → 810.2 and a qualitative ion with a mass-to-charge ratio of m/z 639.6 → 753.1; SEQ ID NO.2 selects the quantitative ion with mass/charge ratio m/z852.1 → 1144.6, the qualitative ion with m/z852.1 → 875.4.
The two polypeptides with characteristics of Syngnathus, the application thereof and the method for identifying Syngnathus are described in detail in the following examples, but the technical scheme of the invention includes but is not limited to the following examples.
Triple quadrupole mass spectrometry conditions
Gradient elution was carried out using 0.1% formic acid acetonitrile as mobile phase A and 0.1% formic acid solution as mobile phase B (0-3min, 5%. A → 8%. A); the flow rate was 0.5ml per minute. Performing Multiple Reaction Monitoring (MRM) by using a mass spectrum detector and an electrospray positive ion mode (ESI +), wherein the mass charge ratio of quantitative ions with m/z 639.6 → 810.2 and the mass charge ratio of qualitative ions with m/z 639.6 → 753.1 are selected from SEQ ID NO. 1; SEQ ID NO.2 selects the quantitative ion with mass/charge ratio m/z852.1 → 1144.6, the qualitative ion with m/z852.1 → 875.4.
Example 1: quasi-sea dragon characteristic peptide segment search
(1) Preparation of test solution
Sea dragon water extract: taking 100g of a test sample Syngnathus, crushing, putting into a triangular flask, adding water, decocting for three times, namely 4h,3h and 2h, combining the decoctions to be 500mL, slightly boiling, concentrating to be viscous, transferring into a silica gel bowl, and drying in an electric heating constant-temperature air drying oven at 60 ℃ until the Syngnathus water extract is solid to obtain the Syngnathus water extract;
test solution: weighing 0.1g of Syngnathus aqueous extract sample, adding 50ml of 1% ammonium bicarbonate aqueous solution, performing ultrasonic treatment for 30min for dissolving, filtering with microporous membrane, collecting 100 μ L of filtrate, adding 10 μ L of 1mg/ml trypsin aqueous solution, performing enzymolysis at 37 deg.C for 2h, taking out, and cooling to room temperature.
(2) Selection of characteristic ions and sequence estimation
After the test solution is analyzed by nanoliter liquid chromatography-high resolution mass spectrometry, mass spectrum data is imported into PEAKS 8.5 software, de novo sequencing and sequence prediction of all peptide segments of the sample are carried out, and the obtained result is analyzed. And selecting peptide fragments which can be detected only in the Syngnathus sp and are hardly detected in other species of Syngnathus sp as parent ions from the analysis results, analyzing the secondary spectra one by one, and selecting daughter ions with better response. Further analysis yielded mass spectral ion pair information representing the variability of Syngnathus m/z 639.6 double charge) → 810.2, 753.1 and m/z852.1 (double charge) → 1144.6, 875.4. Through further analysis, the characteristic peptide fragment sequence of the syngnathus sp corresponding to the ion is presumed, and the sequence shown in SEQ ID NO.1: NAGPQGPQGAAGPR, SEQ ID NO.2: QTGGAGSPATTGFPSGPGR.
And (3) entrusting and synthesizing a quasi-sea dragon characteristic peptide reference substance according to the presumed amino acid sequence, simultaneously detecting the reference substance and the quasi-sea dragon test sample solution, and confirming the correctness of the sequence by keeping the retention time of the reference substance and the quasi-sea dragon test sample solution consistent with the second-level mass spectrum information.
Example 2: research on specificity of Syngnathus pseudopeptides
The water extracts of all species of the syngnathus were detected by triple quadrupole mass spectrometry, and the results showed that all three species of the syngnathus exhibited a characteristic peptide chromatographic peak, while none of the other multi-swallow syngnathus, shushi syngnathus, baojia gungsonian, jonghui syngnathus, and gelsemium were associated with a chromatographic peak. See fig. 1-9 and fig. 10-18. The characteristic peptide is specific to the Syngnathus, and can be used as an index component for identifying the Syngnathus.
Example 3: application of syngnathus characteristic peptide in syngnathus powder extract and syngnathus medicinal liquor
(1) Sample preparation
Preparing a test solution of a syngnathus powder extracting solution: taking 1g of a test sample, crushing, putting into a triangular flask, adding water, decocting for three times, respectively 4h,3h and 2h, combining decoction liquids, weighing 50mL in total, weighing 1mL to 5mL of measuring flask, adding 100 mu l of 1mg/mL trypsin aqueous solution, shaking up, adding 1% ammonium bicarbonate aqueous solution to a constant volume to scale, shaking up, sealing, carrying out enzymolysis at 37 ℃ for 2h at constant temperature, cooling, filtering, and taking a subsequent filtrate as a test sample solution.
Preparing a test solution of the Syngnathus medicinal liquor: taking 10g of Syngnathus in the Syngnathus medicated liquor, drying at low temperature, decocting with water for three times, respectively for 4h,3h and 2h, and mixing the decoctions to obtain 50mL; filtration was carried out, and the filtrate was taken in 1ml to 5ml measuring bottles and prepared as above from "100. Mu.l of 1mg/ml trypsin aqueous solution was added".
Quasi-sea dragon characteristic peptide fragment reference substance solution: respectively weighing 10mg of each of the quasi-Syngnathus characteristic peptide reference substances SEQ ID NO.1 and SEQ ID NO.2, placing in a 50ml measuring flask, adding water to dissolve, and metering to a certain volume to obtain the final product.
(2) The measurement was performed under triple quadrupole mass spectrometry conditions.
(3) Sample assay
And (3) measuring 10 collected quasi-sea dragon powder extract samples and 5 collected quasi-sea dragon medicinal liquor samples, and detecting quasi-sea dragon characteristic peptides in results, wherein the two characteristic peptides can be used for identifying quasi-sea dragon components in sea dragon products.
Example 4: ion information with discrimination potential
5 pieces of ion information with identification potential are screened from 350 candidate ions, triple quadrupole mass spectrometry verifies that the identification of the pseudo-pipefish component can not be realized by any ions, the specificity of part of ions to the pseudo-pipefish is insufficient, the specificity of ions with the mass-to-nuclear ratio of 639.6 and 852.1 is good, and specific results are shown in table 1.
TABLE 1 results of the specificity verification
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Sequence listing
<110> Shandong province food and drug inspection research institute
<120> quasi-sea dragon characteristic polypeptide, application thereof and method for identifying quasi-sea dragon
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 14
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 1
Asn Ala Gly Pro Gln Gly Pro Gln Gly Ala Ala Gly Pro Arg
1 5 10
<210> 2
<211> 19
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Gln Thr Gly Gly Ala Gly Ser Pro Ala Thr Thr Gly Phe Pro Ser Gly
1 5 10 15
Pro Gly Arg
Claims (10)
1. A sea dragon-like characteristic polypeptide is characterized in that the amino acid sequence of the characteristic polypeptide is shown as SEQ ID NO.1 and/or SEQ ID NO. 2.
2. Use of the polypeptide according to the characteristics of claim 1 for identifying a Syngnathus.
3. Use according to claim 2, wherein said identification is carried out using mass spectrometry, and wherein the detection of ion pairs by SEQ ID No.1 comprises: quantitative ions with mass-to-charge ratio of m/z 639.6 → 810.2, and qualitative ions with mass-to-charge ratio of m/z 639.6 → 753.1; the detection ion pair of SEQ ID NO.2 comprises: quantitative ions with mass-to-charge ratio of m/z852.1 → 1144.6, and qualitative ions with mass-to-charge ratio of m/z852.1 → 875.4.
4. A method for identifying Syngnathus sp, which comprises using the polypeptide of claim 1 as a reference.
5. The authentication method according to claim 4, comprising the steps of:
(1) Preparing a test solution: mixing the pretreated pipefish powder extract or the pretreated pipefish medicinal liquor extract with trypsin respectively to obtain a mixed solution, mixing the mixed solution with an ammonium bicarbonate aqueous solution, carrying out enzymolysis and filtering, and taking a filtrate to obtain a test solution;
(2) Preparation of control solutions: respectively dissolving the Syngnathus pseudopterus characteristic peptide of claim 1 in water to obtain reference solutions;
(3) Detection and analysis: detecting and analyzing by using a triple quadrupole mass spectrometry;
the steps (1) or (2) are not limited in chronological order.
6. The method according to claim 5, wherein in step (1), the preparation method of the pretreated Syngnathus powder comprises the steps of: mixing Syngnathus powder with water, decocting for three times (4 h,3h and 2 h), mixing decoctions, and diluting with ammonium bicarbonate water solution to obtain pretreated Syngnathus powder extractive solution;
the preparation process of the pretreated pipefish medicinal liquor extracting solution comprises the following steps: taking out Syngnathus in Syngnathus medicated liquor, drying at low temperature, decocting with water for three times (4 h,3h and 2h respectively), mixing decoctions, filtering, and collecting filtrate to obtain pretreated Syngnathus medicated liquor extract.
7. The method according to claim 5, wherein the trypsin is added in the form of an aqueous trypsin solution, wherein the mass concentration of the trypsin in the aqueous trypsin solution is 1mg/ml.
8. The method of claim 5, wherein the aqueous ammonium bicarbonate solution comprises 1% ammonium bicarbonate by weight; the enzymolysis condition is enzymolysis for 2 hours at 37 ℃.
9. The method of claim 5, wherein the triple quadrupole mass spectrometry is performed with 0.1% formic acid acetonitrile as mobile phase A and 0.1% formic acid solution as mobile phase B, and the gradient elution is performed: 0-3min, 5%; the flow rate was 0.5ml per minute.
10. The method of claim 5, wherein the triple quadrupole mass spectrometry is monitored by multiple reactions using a mass spectrometer detector in electrospray positive ion mode, and wherein SEQ ID No.1 selects the quantitative ions with mass to charge ratio m/z 639.6 → 810.2, the qualitative ions with mass to charge ratio m/z 639.6 → 753.1 are used as the detecting ion pair, and SEQ ID No.2 selects the quantitative ions with mass to charge ratio m/z852.1 → 1144.6, and the qualitative ions with mass to charge ratio m/z852.1 → 875.4 are used as the detecting ion pair.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210653950.9A CN115246873A (en) | 2022-06-10 | 2022-06-10 | Syngnathus characteristic polypeptide, application thereof and method for identifying Syngnathus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210653950.9A CN115246873A (en) | 2022-06-10 | 2022-06-10 | Syngnathus characteristic polypeptide, application thereof and method for identifying Syngnathus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115246873A true CN115246873A (en) | 2022-10-28 |
Family
ID=83699057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210653950.9A Pending CN115246873A (en) | 2022-06-10 | 2022-06-10 | Syngnathus characteristic polypeptide, application thereof and method for identifying Syngnathus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115246873A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111303263A (en) * | 2020-03-11 | 2020-06-19 | 中国药科大学 | Earthworm characteristic polypeptide and application thereof in species identification of earthworm medicinal materials |
CN114113381A (en) * | 2021-11-12 | 2022-03-01 | 山东省食品药品检验研究院 | Characteristic polypeptide of saloon, application thereof and method for identifying comfortable saloon |
-
2022
- 2022-06-10 CN CN202210653950.9A patent/CN115246873A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111303263A (en) * | 2020-03-11 | 2020-06-19 | 中国药科大学 | Earthworm characteristic polypeptide and application thereof in species identification of earthworm medicinal materials |
CN114113381A (en) * | 2021-11-12 | 2022-03-01 | 山东省食品药品检验研究院 | Characteristic polypeptide of saloon, application thereof and method for identifying comfortable saloon |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114113381B (en) | Syngnathus schutz characteristic polypeptide, application thereof and method for identifying comfortable Syngnathus schutz | |
CN113307846A (en) | Characteristic polypeptide for identifying deer antlers of sika deer or red deer and application thereof | |
CN113480599A (en) | Characteristic polypeptide for identifying deer antler glue of sika deer or red deer and application thereof | |
CN105223290B (en) | A kind of method and application measuring hemoglobin alpha and beta globin chain ratio | |
CN109280077A (en) | A kind of identification donkey-hide gelatin and the polypeptide containing pigskin derived component in donkey-hide gelatin product | |
CN105837676A (en) | Group of polypeptides for identification of bovine-derived ingredient in donkey-hide gelatin and products thereof | |
CN111896651A (en) | Agkistrodon halys venom thrombin-like enzyme characteristic polypeptide and application thereof | |
CN115060822B (en) | Fingerprint spectrum quantitative analysis method based on traditional Chinese medicine 'imprinting template' component clusters | |
WO2023082512A1 (en) | Stiff silkworm marker polypeptide and method for identifying stiff silkworms, stiff silkworm aqueous extract products and other stiff silkworm products | |
CN110346479A (en) | The extraction of the endogenous peptide of one seed oyster and identification method | |
CN113502279A (en) | Pallas pit viper venom phospholipase A2 characteristic polypeptide and application thereof | |
Shi et al. | Rapid screening of illegally added drugs in functional food using a miniature ion trap mass spectrometer | |
CN109374785B (en) | Construction method and detection method of UPLC (ultra performance liquid chromatography) characteristic spectrum of lophatherum gracile medicinal material | |
CN107688056B (en) | Liquid chromatography-mass spectrometry detection method for identifying pangolin scales | |
CN114354772B (en) | Screening method and application of characteristic polypeptide combination for detecting turtle shell and tortoise shell | |
CN118150722A (en) | Method for determining efficacy of cordyceps sinensis based on systemic biological response | |
CN102967670A (en) | Method for measuring cordycepin, adenosine and mannitol in cordyceps sinensis mycelium powder | |
CN117368340A (en) | LC-Q-TOF-based identification method of adulterated ginger processed pinellia tuber in ginger processed pinellia tuber | |
CN115246873A (en) | Syngnathus characteristic polypeptide, application thereof and method for identifying Syngnathus | |
CN115248277B (en) | Cynanchum paniculatum characteristic polypeptide, application thereof and method for identifying Cynanchum paniculatum | |
CN107519223A (en) | Ginseng extract and its preparation and measure containing endogenous polypeptide, the medicine containing ginseng extract or pharmaceutical composition and its application | |
CN112345655A (en) | Establishing method of wasp venom fingerprint, wasp venom fingerprint and application of wasp venom fingerprint | |
CN115710308A (en) | Characteristic polypeptide and application thereof | |
CN115925808A (en) | Characteristic polypeptide of asparagus sea, application thereof and method for identifying asparagus sea | |
CN109444287A (en) | A kind of LC-MS/MS quantitative detecting method of alpha-fetoprotein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |